Ginkgo Bioworks Announces Participation in Upcoming Conferences

News provided by

Nov 24, 2021, 07:00 ET

BOSTON, Nov. 24, 2021 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences:

Piper Sandler Annual Healthcare Conference on Tuesday, November 30, 2021
Jefferies Alternative Protein & Related ESG Summit on Wednesday, December 1, 2021 at 6:30 p.m. ET
Goldman Sachs Byte-ology: The Convergence of Biotechnology and Technology Conference on Thursday, December 9, 2021 at 11:00 a.m. ET

Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:
[email protected]

MEDIA CONTACT:
[email protected]

SOURCE Ginkgo Bioworks